Xeris Biopharma(XERS) - 2024 Q3 - Quarterly Results

Exhibit 99.1 XERIS BIOPHARMA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS Achieved record total revenue of $54.3M including record product revenue of $52.9M Product revenue increased 27% versus prior year and 14% over the prior quarter Ended Q3 with $69.4M in cash, cash equivalents and short-term investments Raises full-year guidance of total net revenue to $198M-$202M and tightens year-end cash to $68M-$72M Hosting conference call and webcast today at 8:30 a.m. ET CHICAGO, IL; November 8, 2024 – Xeris Biop ...